Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in The Finsen Centre, National Hospital.

During the past decade, The Finsen Centre, National Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Finsen Centre, National Hospital" are "Lymphoma" (2 trials), "Accelerated Phase Chronic Myeloid Leukemia" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Lymphocytic Leukemia" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "The Finsen Centre, National Hospital" in a lesser frequency.

Most popular intervention types in "The Finsen Centre, National Hospital" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Pemigatinib" (3 trials), "Parsaclisib" (2 trials), "Pembrolizumab" (2 trials), "Retifanlimab" (2 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Finsen Centre, National Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "The Finsen Centre, National Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Finsen Centre, National Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Finsen Centre, National Hospital, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".